Marfan syndrome is a medical condition that affects connective tissue, which holds the body’s cells, organs, and tissue together and helps the body grow and develop properly. It is a genetic disorder, meaning that it starts in the genes that are passed down from parents to children. Because connective tissue is found throughout the body, Marfan syndrome can cause problems in many areas, including the heart, blood vessels, bones, joints, and eyes. The lungs, skin, and nervous system also may be affected.
Some problems caused by Marfan syndrome can be life-threatening, such as aortic enlargement (expansion of the aorta, the main vessel that carries blood from the heart to the rest of the body). Symptoms of Marfan syndrome may not appear until adulthood and can get worse over time. Some estimates suggest that half of the people with the condition don’t know they have it. Available therapies are more effective the earlier the condition is detected and treated.
UAB Medicine operates a Marfan Syndrome and Related Disorders Clinic, which is a multi-specialty clinic that includes physicians from the UAB Department of Pediatric Cardiology and the UAB Department of Genetics. Services offered include physical exams, echocardiogram/EKG, and genetic testing for diseases and conditions of the aorta, when needed. The clinic’s genetic counselor works with patients to help them better understand their condition and evaluate their risk for medical issues based on genetic testing results.
Because Marfan syndrome can affect the heart, patient care also may be provided by the UAB Congenital Heart Disease Program. The program offers the most advanced care for congenital (present at birth) heart disease, which often requires lifetime monitoring and care. Our multi-specialty team of pediatric and adult cardiologists, cardiovascular surgeons, cardiovascular anesthesiologists, and maternal-fetal medicine specialists have unique expertise in treating patients before birth and into adulthood.
UAB Medicine’s modern ultrasound equipment allows many heart defects to be diagnosed before a child is born. Screening exams performed at 18-20 weeks are recommended for expecting mothers or fathers known to have congenital heart disease. If a defect is discovered, our experts provide prenatal treatment and develop a plan for delivery and treatment after birth.
Thanks to advances in pediatric congenital care, the life expectancy for most patients now reaches far into adulthood. However, more than half of the people with congenital heart problems stop seeing a cardiologist once they turn 18. UAB’s Alabama Adult Congenital Heart Disease Program is designed to prevent that gap in care. As the only adult congenital heart disease program in the state and one of only a few in the country, our expertise greatly increases the chances that symptoms will be identified early. This helps ensure that less serious problems are addressed before they develop into larger, more life-threatening issues such as heart failure, arrhythmia, residual congenital heart defects, endocarditis, and stroke.
Meet the Team: Kyle Eudailey, MD
Dr. Eudailey specializes in adult cardiac surgery, including aortic surgery and transcatheter treatment of valve disease. He is grateful for the opportunity to help patients improve their quality of life.
Dr. Cribbs on Business Break
More than 20,000 adults enter the Adult Congenital Heart Disease population every year, but 60% are lost to follow-up care.
Care of Adults with Congenital Heart Disease
Fetal Cardiac Services at UAB Medicine
Drs. Joseph R. Biggio and Robb L. Romp discuss how the UAB Fetal Diagnosis and Care Center brings together experts at UAB Medicine and Children's of Alabama Joseph S. Bruno Pediatric Heart Center to care for high risk moms and babies from the moment a congenital abnormality is suspected.
Individuals born with congenital heart disease are now thriving into adulthood, but need lifelong follow-up care from sub-specialty experts.
Adult Congenital Heart Disease Risk Factors, Symptoms & Treatments
Some people are born with a defect or malformation in their heart or blood vessels, and this is called Congenital Heart Disease. UAB Cardiologist Edward Colvin, MD, talks to Daytime Alabama on WVTM-TV, Channel 13, in Birmingham, Ala., about the types of congenital heart disease and what adults with this disease should look for when choosing a doctor.
UAB is an active participant in research and clinical trials for Marfan Syndrome. We encourage you to speak to your physician about research and clinical trial options and browse the link below for more information.View Clinical Trials
Study shows some heart disease patients implanted with a VAD have better survival and are more likely to receive a heart transplant
UAB Cardiovascular Institute is Nationally Recognized for its Commitment to Providing High-Quality Heart Care
Heart-Healthy Tailgates for the Win
UAB Physicians Using Mpirik Cardiac Intelligence to Address Health Inequities
Recent Advancements Make it Easier to Live Well with Atrial Fibrillation